New shot aims to tame tough seasonal allergies
NCT ID NCT07291284
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental injection called LP-003 in 546 adults with moderate to severe seasonal allergic rhinitis (hay fever) that standard medications don't manage well. Participants receive either the drug or a placebo, and report their nasal symptoms daily. The goal is to see if LP-003 safely reduces symptoms like sneezing, stuffiness, and runny nose during peak pollen season.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEASONAL ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Shijitan Hospital, Capital Medical University (the formerly Beijing Railway General Hospital)
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pinpoint pollen dose unmask allergy triggers?
- New allergy pill could offer relief from sneezing and stuffy nose
- New injection could tame seasonal allergy symptoms for those failed by standard treatments
- New shot for teen hay fever? early trial underway
- Nasal spray test could make allergy shots smarter and cheaper
- New allergy drug AK139 aims to stop sneezing and stuffy noses